+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Buffer Preparation Market: Focus on Buffer Manufacturing Systems and Service Providers - Distribution by Scale of Operation (Preclinical / Clinical and Commercial) and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

  • PDF Icon

    Report

  • 144 Pages
  • June 2023
  • Region: Global
  • Roots Analysis
  • ID: 5836051

Buffer Preparation Market Overview

The global buffer preparation systems market is anticipated to grow at a CAGR of around 10%, till 2035. Buffers are aqueous solutions used to control pH in drug manufacturing process and are a vital component in maintaining the stability of both biologics and small molecules during production and in their final form. Moreover, buffers are used in multiple upstream and downstream bioprocesses for various applications, including maintaining the stable pH of culture, enhancing yield of desired products, maintaining defined purification conditions and stabilizing the final product while maintaining its functional characteristics. However, conventional buffer manufacturing is a complex process that requires large floor space and trained labor. In addition, conventional buffer production is a time consuming, multistep process that contributes to high production costs as well as batch-to-batch variations in the final products. In fact, as per a report by BioPharma, preparation of a 2,000 L buffer is expected to take more than 35 hours.

To overcome the challenges associated with conventional buffer preparation / buffer manufacturing processes, pharmaceutical players are either installing novel buffer preparation systems in their manufacturing facilities or outsourcing buffer manufacturing needs to third party service providers. In recent years, the use of buffer manufacturing / buffer management systems has witnessed rapid adoption trends. This can be attributed to the fact that these systems occupy less floor space and are integrated with advanced technologies for maintaining physiological conditions of buffers during the downstream processes. It is worth mentioning that novel buffer preparation systems can manufacture 2,000 L buffer within 40-50 minutes. In fact, as per a report by Pall Corporation, the use of buffer management systems can result in a 50% reduction in labor costs and a 12% decrease in buffer manufacturing costs. Additionally, outsourcing the complex process of buffer manufacturing is expected to result in an annual savings of USD 90,000 and a 75% reduction in buffer preparation time. Driven by the growing demand for buffers and challenges associated with buffer manufacturing, the buffer preparation systems market is anticipated to witness steady growth in the coming decade.

Key Market Insights

The Buffer Manufacturing Market: Focus on Buffer Manufacturing Systems and Service Providers - Distribution by Scale of Operation (Preclinical / Clinical and Commercial) and Key Geographical Regions (North America, Europe, Asia and Rest of the World): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape, market size and future opportunities for the players engaged in the development of buffer management systems and providing buffer manufacturing services. The report answers many key questions related to this industry.

Need for Novel Buffer Preparation Systems

Buffer manufacturing has been one of the most crucial processes in the biopharmaceutical industry with wide range of applications. However, buffer production is an expensive, lengthy and labor-intensive process that requires significant floor space and specialized equipment. Additionally, buffer storage during the large scale production of biopharmaceuticals can be a challenge as buffer storage requires a large floor space at a time when emerging product classes are driving the need for multi-use, multi-scale manufacturing. 

In order to address the aforementioned challenges associated with buffer preparation and buffer storage, several players have developed novel buffer preparation systems / in-line conditioning systems which enable simultaneous preparation of buffer from raw materials and their use in upstream and downstream applications. Integrated with automated technology platforms and sensors, such systems have allowed precise and controlled production of buffers in timebound manner. It is worth highlighting that the use of novel buffer preparation systems / inline buffer conditioning systems has already demonstrated promising results in buffer manufacturing, in terms of process automation, time reduction and buffer quality. For instance, NIIMBL-BioPhorum Buffer Stock Blending Skid claims to manufacture 4,000 L of buffer in two hours, compared to the six to eight hours needed for traditional buffer manufacturing process.

Buffer Manufacturing Systems Market Landscape

Presently, close to 45 buffer preparation / manufacturing systems are available in the market for buffer production. Such buffer preparation systems can automate buffer production process across different scales of operations. It is worth highlighting that the novel buffer manufacturing systems are integrated with a wide range of features, including conductivity sensors, pressure sensors, temperature sensors, pH sensors and filters. Notably, a large number of buffer manufacturing systems have been developed to operate in an automated mode, reducing the risk of errors prone to human interface. In addition, over 20% of the buffer manufacturing systems offer preparation of both diluted and conditioned buffers, offering flexibility to users. In November 2021, California based Agilitech launched their automated single-use inline dilution system that offers dilution of concentrated buffer solutions and their delivery for downstream processes at the point of use and time of use.

Need for Outsourcing Buffer Manufacturing Services to Contract Manufacturers

Given the technical and operational challenges associated with the production of buffers, innovators in the biopharmaceutical industry are increasingly relying on the contract service providers for their buffer manufacturing needs. The buffer preparation service provider landscape consists of close to 45 players, featuring a mix of start-ups and experienced large players, that claim to provide services for buffer preparation across different scales of operations. Notably, majority of the players established post-2000 are headquartered in North America, primarily in the US. It is worth highlighting that more than 45% of the service providers offer at least three services in this domain, such as fill / finish and packaging, formulation development and manufacturing services for buffers.

Partnership and Collaboration Trends in Buffer Preparation Market

Stakeholders in the buffer manufacturing industry have forged several deals in order to enhance their product portfolios and augment the reach of their proprietary buffer manufacturing systems. It is worth highlighting that over 40% of these partnerships have been inked since 2021. Majority of such deals are focused on acquisitions, followed by distribution agreements and strategic alliances. In May 2023, GeminiBio signed an agreement with Asahi Kasei Bioprocess America to improve biomanufacturing process by using latter’s inline buffer management system, MOTIV.

Key Drivers for the Buffer Preparation Systems Market

The growing demand for biological buffers is one of the key drivers for the buffer manufacturing systems market. In addition, the need for automated buffer preparation systems is expected to drive the buffer manufacturing market size during the forecast period.

Market Size of Buffer Manufacturing / Buffer Preparation Systems 

Driven by the growing demand for buffers and challenges associated with buffer preparation and buffer storage, the buffer manufacturing systems market is anticipated to grow at a CAGR of ~10% in the forecast period. It is worth highlighting that more than 65% of the current market share is captured by players based in North America and Europe.

Key Companies in the Buffer Manufacturing Market

Examples of the key players in this industry (the complete list of players is available in the full report) include Asahi Kasei, Avantor, Canvax, Cytiva, Lonza, Merck, Pall Corporation, Thermo Fisher Scientific and Uniogen.

Scope of the Report

The report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different regions. Amongst other elements, the report includes:

  • An executive summary of the insights captured during our research, offering a high-level view on the current state of the buffer preparation systems market and its likely evolution in the mid-to-long term.
  • A general overview of buffer manufacturing, along with information on conventional and novel methods of buffer manufacturing. In addition, the chapter highlights the challenges associated with buffer manufacturing, advantages of outsourcing buffer manufacturing and key considerations while selecting an outsourcing partner. Further, it concludes with a discussion on future perspectives in this market.
  • A detailed assessment of the overall market landscape of buffer preparation / manufacturing systems, based on several relevant parameters, such as type of system (whole unit and buffer tank), mode of operation (automatic and manual), scale of operation (preclinical, clinical and commercial), vessel fabrication material(s) (stainless steel, polymer and others), system mobility option (mobile and stationary), feature(s) of buffer manufacturing system (conductivity sensor, pH sensor, temperature sensor, pressure sensor, filter and others), integrated technique(s) (chromatography, filtration and others), buffer manufacturing process (batch and continuous), type of buffer form(s) (conditioned buffers and diluted buffers) and bioprocessing method (downstream and upstream). In addition, it provides an in-depth analysis of the buffer manufacturing system providers, based on their year of establishment, company size, location of headquarters and most active players (in terms of number of buffer manufacturing systems offered).
  • A comprehensive product competitiveness analysis of buffer manufacturing systems, based on developer power (in terms of number of years of experience of a company) and product competitiveness (in terms of type of system, mode of operation, scale of operation, vessel fabrication material(s), system mobility option, feature(s) of buffer manufacturing system, integrated technique(s), buffer manufacturing process, buffer form(s), bioprocessing method, availability of GMP manufacturing and single use components).
  • Elaborate profiles of key players (shortlisted based on proprietary criterion) engaged in the development of buffer preparation systems, including a brief overview of the company, details related to product portfolio, recent developments and an informed future outlook. 
  • A detailed assessment of the overall market landscape of buffer manufacturing service providers, based on several relevant parameters, such as year of establishment, company size, location of headquarters, location of facilities, scale of operation (pre-clinical, clinical and ready-to-use buffers), buffer(s) manufactured (acetate buffers, amino acid buffers, borate buffer, carbonate / bicarbonate buffers, citrate buffers, potassium buffers, phosphate buffers, sodium buffers and other buffers), buffer formulation (liquid and powder), buffer packaging format (bags, bioprocess containers, bottles, polymer drums, and other types of packaging), compatible biologic(s) (antibody, cell therapy, enzyme, nucleic acid, peptide / protein, vaccine and other types of compatible biologics), application area(s) (drug development, drug manufacturing, purification, research and other application area), type of service (fill / finish and packaging, formulation development, manufacturing, process development, scale-up and other types of services) and most active players (in terms of number of facilities and number of services).
  • A comprehensive company competitiveness analysis of buffer manufacturing service providers based in North America, Europe and Asia, based on supplier power (in terms of number of years of experience of a company) and company competitiveness (in terms of number of facilities, location of facilities, scale of operation, type of buffer(s) provided, buffer(s) manufactured, buffer formulation, buffer packaging format, compatible biologic(s), application area(s), type of service and availability of GMP manufacturing).
  • Elaborate profiles of key companies (shortlisted based on proprietary criterion) providing buffer manufacturing services including a brief overview of the company, key executives, company portfolio, recent developments and an informed future outlook. 
  • A detailed analysis of partnerships inked between stakeholders engaged in this industry, since 2017, based on several relevant parameters, such as year of partnership, type of partnership (acquisitions, commercialization agreements, development agreements, distribution agreements, manufacturing agreements, product development agreements, product distribution agreements, product integration and distribution agreements, product / technology installation agreements, research and development agreements, service agreements, strategic alliances, and others, type of partner, company size, most active players (in terms of the number of partnerships signed) and regional distribution of partnership activity in this domain.

One of the key objectives of this research report was to estimate the current opportunity, market size and the future growth potential of the buffer manufacturing market during the forecast period. We have provided an informed estimate on the likely evolution of the market in mid-to-long term for the period, 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as scale of operation (preclinical / clinical and commercial), and key geographical regions (North America, Europe, Asia and Rest of the World). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios of the industry’s evolution.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Frequently Asked Questions

Question 1: What are buffer preparation systems? 

Answer: A buffer preparation system prepares buffers to be used in various stages of recovery operations. The buffer prep system contains equipment used for large scale and small scale buffer preparation.

Question 2: What is in line dilution?

Answer: Inline dilution is an added capability to chromatography systems that brings multiple process streams together to dilute or blend a solution at the point of use. Buffer and process solutions are mixed with water to meet the targeted final buffer composition.

Question 3: What is the need for novel buffer preparation systems? 

Answer: Buffer management / manufacturing is a complex process that requires extensive cost, floor space, trained labor and is prone to human errors. To overcome these challenges, novel buffer preparation systems have been developed that offer several advantages, including automation of buffer manufacturing process, shortened manufacturing timeless, requirement of less floor space and production of high quality buffers. 

Question 4: How many players have developed / are currently engaged in the development of buffer preparation systems?

Answer: Presently, close to 30 companies are engaged in the development and distribution of proprietary buffer preparation systems worldwide. Some of the established players engaged in this industry include Asahi Kasei, Avantor, Cytiva, Genentech, Merck, Pall Corporation, Parker Hannifin, Sartorius and Thermo Fisher Scientific. 

Question 5: What types of partnerships are most common in the field of buffer preparation systems?

Answer: Acquisitions are the most common types of partnerships inked by stakeholders that are engaged in the development and distribution of proprietary buffer preparation systems, followed by strategic alliances and distribution agreements.

Question 6: How many players provide services related to buffer manufacturing?

Answer: Presently, more than 40 players located across the globe claim to provide services related to buffer manufacturing to pharmaceutical companies, research institutions and other end users.

Question 7: What is the likely growth rate (CAGR) of buffer preparation systems market?

Answer: The buffer manufacturing systems market is expected to grow at a CAGR of ~10% during the forecast period.

Question 8: Which region has the highest market share in the buffer manufacturing market?

Answer: Currently, North America is expected to capture the maximum share of the buffer manufacturing systems market. Further, Asia is likely to grow at a considerable pace during the forecast period.

Table of Contents

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Key Questions Answered
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Buffer Manufacturing
3.2.1. Conventional Methods of Buffer Manufacturing
3.2.2. Novel Methods of Buffer Manufacturing
3.3. Challenges Associated with Buffer Manufacturing
3.4. Advantages of Outsourcing Buffer Manufacturing
3.5. Key Considerations While Selecting an Outsourcing Partner
3.6. Future Perspectives

4. MARKET LANDSCAPE: BUFFER MANUFACTURING SYSTEMS
4.1. Chapter Overview
4.2 Buffer Manufacturing System: Overall Market Landscape
4.2.1. Analysis by Type of System
4.2.2. Analysis by Mode of Operation
4.2.5. Analysis by Scale of Operation
4.2.6. Analysis by Vessel Fabrication Material(s)
4.2.7. Analysis by System Mobility Option
4.2.8. Analysis by Feature(s) of Buffer Manufacturing System
4.2.9. Analysis by Integrated Technique(s)
4.2.10. Analysis by Buffer Manufacturing Process
4.2.11. Analysis by Type of Buffer Form(s)
4.2.12. Analysis by Bioprocessing Method
4.3. Buffer Manufacturing System Providers Landscape
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Location of Headquarters
4.3.3. Analysis by Company Size
4.3.4. Most Active Players: Analysis by Number of Products Offered

5. PRODUCT COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Product Competitiveness Analysis
5.4.1. Buffer Manufacturing Systems Offered by Companies based in North America
5.4.2. Buffer Manufacturing Systems Offered by Companies based in Europe
5.4.3. Buffer Manufacturing Systems Offered by Companies based in Asia

6. COMPANY PROFILES: BUFFER MANUFACTURING SYSTEM PROVIDERS
6.1. Chapter Overview
6.2. Asahi Kasei
6.2.1. Company Overview
6.2.2. Product Portfolio
6.2.3. Recent Developments and Future Outlook
6.3 Cytiva
6.3.1. Company Overview
6.3.2. Product Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. Pall Corporation
6.4.1. Company Overview
6.4.2. Product Portfolio
6.4.3. Recent Developments and Future Outlook
6.5 Thermo Fisher Scientific
6.5.1. Company Overview
6.5.2. Product Portfolio
6.5.3. Recent Developments and Future Outlook

7. MARKET LANDSCAPE: BUFFER MANUFACTURING SERVICE PROVIDERS
7.1. Chapter Overview
7.2. Buffer Manufacturing Service Providers: Overall Market Landscape
7.2.1. Analysis by Year of Establishment
7.2.2. Analysis by Company Size
7.2.3. Analysis by Location of Headquarters
7.2.4. Analysis by Location of Facilities
7.2.5. Analysis by Scale of Operation
7.2.6. Analysis by Type of Buffer(s) Provided
7.2.7. Analysis by Buffer(s) Manufactured
7.2.8. Analysis by Buffer Formulation
7.2.9. Analysis by Buffer Packaging Format
7.2.10. Analysis by Compatible Biologic(s)
7.2.11. Analysis by Application Area(s)
7.2.12. Analysis by Type of Service
7.2.13. Most Active Players: Analysis by Number of Facilities
7.2.15. Most Active Players: Analysis by Number of Services

8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Assumptions and Key Parameters
8.3. Methodology
8.4. Company Competitiveness Analysis
8.4.1. Buffer Manufacturing Service Providers based in North America
8.4.2. Buffer Manufacturing Service Providers based in Europe
8.4.3. Buffer Manufacturing Service Providers based in Asia

9. COMPANY PROFILES: BUFFER MANUFACTURING SERVICE PROVIDERS
9.1. Chapter Overview
9.2. Avantor
9.2.1. Company Overview
9.2.2. Buffer Manufacturing Service Portfolio
9.2.3. Recent Developments and Future Outlook
9.3 Canvax
9.3.1. Company Overview
9.3.2. Buffer Manufacturing Service Portfolio
9.3.3. Recent Developments and Future Outlook
9.4. Lonza
9.4.1. Company Overview
9.4.2. Buffer Manufacturing Service Portfolio
9.4.3. Recent Developments and Future Outlook
9.5 Merck
9.5.1. Company Overview
9.5.2. Buffer Manufacturing Service Portfolio
9.5.3. Recent Developments and Future Outlook
9.6. Uniogen
9.6.1 Company Overview
9.6.2. Buffer Manufacturing Service Portfolio
9.6.3 Recent Developments and Future Outlook

10. PARTNERSHIPS AND COLLABORATIONS
10.1. Chapter Overview
10.2. Partnership Models
10.2.1. Buffer Manufacturing System Providers: List of Partnerships and Collaborations
10.2.2. Analysis by Year of Partnership
10.2.3. Analysis by Type of Partnership
10.2.4. Analysis by Type of Partner
10.2.5. Analysis by Company Size
10.2.6. Analysis by Geography
10.2.6.1. Local and International Agreements
10.2.6.2. Intracontinental and Intercontinental Agreements
10.2.7. Most Active Players: Analysis by Number of Partnerships

11. MARKET FORECAST
11.1. Chapter Overview
11.2. Key Assumptions and Methodology
11.3. Global Buffer Manufacturing Systems Market, 2023-2035
11.3.1. Buffer Manufacturing Systems Market: Distribution by Scale of Operation, 2023 and 2035
11.3.1.1. Buffer Manufacturing Systems Market for Preclinical and Clinical Scale, 2023-2035
11.3.1.2. Buffer Manufacturing Systems Market for Commercial Scale, 2023-2035
11.3.2. Buffer Manufacturing Systems Market: Distribution by Key Geographical Regions, 2023 and 2035
11.3.2.1. Buffer Manufacturing Systems Market in North America, 2023-2035
11.3.2.2. Buffer Manufacturing Systems Market in Europe, 2023-2035
11.3.2.3. Buffer Manufacturing Systems Market in Asia Pacific, 2023-2035
11.3.2.4. Buffer Manufacturing Systems Market in Rest of the World, 2023-2035

12. CONCLUSION13. APPENDIX I: TABULATED DATA14. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
List Of Figures
Figure 2.1 Executive Summary: Overall Market Landscape of Buffer Manufacturing Systems
Figure 2.2 Executive Summary: Overall Market Landscape of Buffer Manufacturing Service Providers
Figure 2.3 Executive Summary: Partnerships and Collaborations
Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Conventional Method of Buffer Manufacturing
Figure 3.2 Novel Methods of Buffer Manufacturing
Figure 3.3 Challenges Associated with Buffer Manufacturing
Figure 4.1 Buffer Manufacturing Systems: Distribution by Type of System
Figure 4.2 Buffer Manufacturing Systems: Distribution by Mode of Operation
Figure 4.3 Buffer Manufacturing Systems: Distribution by Scale of Operation
Figure 4.4 Buffer Manufacturing Systems: Distribution by Vessel Fabrication Material(s)
Figure 4.5 Buffer Manufacturing Systems: Distribution by Type of System and Type of Vessel Fabrication Material(s)
Figure 4.6 Buffer Manufacturing Systems: Distribution by System Mobility Option
Figure 4.7 Buffer Manufacturing Systems: Distribution by Feature(s) of Buffer Manufacturing System
Figure 4.8 Buffer Manufacturing Systems: Distribution by Integrated Technique(s)
Figure 4.9 Buffer Manufacturing Systems: Distribution by Buffer Manufacturing Process
Figure 4.10 Buffer Manufacturing Systems: Distribution by Type of Buffer Form(s)
Figure 4.11 Buffer Manufacturing Systems: Distribution by Bioprocessing Method
Figure 4.12 Buffer Manufacturing System Providers: Distribution by Year of Establishment
Figure 4.13 Buffer Manufacturing System Providers: Distribution by Location of Headquarters
Figure 4.14 Buffer Manufacturing System Providers: Distribution by Company Size
Figure 4.15 Most Active Players: Distribution by Number of Products Offered
Figure 5.1 Product Competitiveness Analysis: Buffer Manufacturing Systems Offered by Companies based in North America
Figure 5.2 Product Competitiveness Analysis: Buffer Manufacturing Systems Offered by Companies based in Europe
Figure 5.3 Product Competitiveness Analysis: Buffer Manufacturing Systems Offered by Companies based in Asia
Figure 7.1 Buffer Manufacturing Service Providers: Distribution by Year of Establishment
Figure 7.2 Buffer Manufacturing Service Providers: Distribution by Company Size
Figure 7.3 Buffer Manufacturing Service Providers: Distribution by Location of Headquarters
Figure 7.4 Buffer Manufacturing Service Providers: Distribution by Location of Facilities
Figure 7.5 Buffer Manufacturing Service Providers: Distribution by Scale of Operation
Figure 7.6 Buffer Manufacturing Service Providers: Distribution by Type of Buffer(s) Provided
Figure 7.7 Buffer Manufacturing Service Providers: Distribution by Buffer(s) Manufactured
Figure 7.8 Buffer Manufacturing Service Providers: Distribution by Buffer Formulation
Figure 7.9 Buffer Manufacturing Service Provider: Distribution by Buffer Packaging Format
Figure 7.10 Buffer Manufacturing Service Providers: Distribution by Compatible Biologic(s)
Figure 7.11 Buffer Manufacturing Service Providers: Distribution by Application Area(s)
Figure 7.12 Buffer Manufacturing Service Providers: Distribution by Type of Service
Figure 7.13 Most Active Players: Distribution by Number of Facilities
Figure 7.14 Most Active Players: Distribution by Number of Services Offered
Figure 8.1 Company Competitiveness Analysis: Buffer Manufacturing Service Providers based in North America
Figure 8.2 Company Competitiveness Analysis: Buffer Manufacturing Service Providers based in Europe
Figure 8.3 Company Competitiveness Analysis: Buffer Manufacturing Service Providers based in Asia
Figure 10.1 Partnerships and Collaborations: Distribution by Year of Partnership
Figure 10.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 10.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 10.4 Partnerships and Collaborations: Distribution by Type of Partner
Figure 10.5 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Figure 10.6 Partnerships and Collaborations: Distribution by Company Size
Figure 10.7 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
Figure 10.8 Partnerships and Collaborations: Local and International Agreements
Figure 10.9 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Figure 10.10 Most Active Players: Distribution by Number of Partnerships
Figure 11.1 Global Buffer Manufacturing Systems Market, 2023-2035 (USD Million)
Figure 11.2 Buffer Manufacturing Systems Market: Distribution by Scale of Operation, 2023 and 2035
Figure 11.3 Buffer Manufacturing Systems Market for Preclinical and Clinical Scale, 2023-2035 (USD Million)
Figure 11.4 Buffer Manufacturing Systems Market for Commercial Scale, 2023-2035 (USD Million)
Figure 11.5 Buffer Manufacturing Systems Market: Distribution by Key Geographical Regions, 2023 and 2035
Figure 11.6 Buffer Manufacturing Systems Market in North America, 2023-2035 (USD Million)
Figure 11.7 Buffer Manufacturing Systems Market in Europe, 2023-2035 (USD Million)
Figure 11.8 Buffer Manufacturing Systems Market in Asia Pacific, 2023-2035 (USD Million)
Figure 11.9 Buffer Manufacturing Systems Market in Rest of the World, 2023-2035 (USD Million)
Figure 12.1 Conducing Remarks: Overall Market Landscape of Buffer Manufacturing Systems
Figure 12.2 Conducing Remarks: Overall Market Landscape of Buffer Manufacturing Service Providers
Figure 12.3 Conducing Remarks: Partnerships and Collaborations
Figure 12.4 Conducing Remarks: Market Forecast

List Of Tables
Table 4.1 Buffer Manufacturing Systems: Information on Type of System, Mode of Operation and Scale of Operation
Table 4.2 Buffer Manufacturing Systems: Information on Vessel Fabrication Material(s) and System Mobility Option
Table 4.3 Buffer Manufacturing Systems: Information on Feature(s) of Buffer Manufacturing System and Integrated Technique(s)
Table 4.4 Buffer Manufacturing Systems: Information on Buffer Manufacturing Process, Type of Buffer Form(s), and Bioprocessing Method
Table 4.5 Buffer Manufacturing Systems: Additional Information
Table 4.6 Buffer Manufacturing System Providers: Information on Year of Establishment, Location of Headquarters and Company Size
Table 6.1 List of Companies Profiled
Table 6.2 Asahi Kasei: Company Overview
Table 6.3 Asahi Kasei: Buffer Manufacturing System Portfolio
Table 6.4 Asahi Kasei: Recent Developments and Future Outlook
Table 6.5 Cytiva: Company Overview
Table 6.6 Cytiva: Buffer Manufacturing System Portfolio
Table 6.7 Cytiva: Recent Developments and Future Outlook
Table 6.8 Pall Corporation: Company Overview
Table 6.9 Pall Corporation: Buffer Manufacturing System Portfolio
Table 6.10 Pall Corporation: Recent Developments and Future Outlook
Table 6.11 Thermo Fisher Scientific: Company Overview
Table 6.12 Thermo Fisher Scientific: Buffer Manufacturing System Portfolio
Table 6.13 Thermo Fisher Scientific: Recent Developments and Future Outlook
Table 7.1 Buffer Manufacturing Service Providers: Information on Year of Establishment, Company Size, Location of Headquarters, Number and Location of Facilities
Table 7.2 Buffer Manufacturing Service Providers: Information on Scale of Operation, Type of Buffer(s) Provided and Buffer(s) Manufactured
Table 7.3 Buffer Manufacturing Service Providers: Information on Buffer Formulation and Buffer Packaging Format
Table 7.3 Buffer Manufacturing Service Providers: Information on Compatible Biologic(s), Application Area(s) and Type of Service
Table 9.1 List of Companies Profiled
Table 9.2 Avantor: Company Overview
Table 9.3 Avantor: Buffer Manufacturing Service Portfolio
Table 9.4 Avantor: Recent Developments and Future Outlook
Table 9.5 Canvax: Company Overview
Table 9.6 Canvax: Buffer Manufacturing Service Portfolio
Table 9.7 Canvax: Recent Developments and Future Outlook
Table 9.8 Lonza: Company Overview
Table 9.9 Lonza: Buffer Manufacturing Service Portfolio
Table 9.10 Lonza: Recent Developments and Future Outlook
Table 9.11 Merck: Company Overview
Table 9.12 Merck: Buffer Manufacturing Service Portfolio
Table 9.13 Merck: Recent Developments and Future Outlook
Table 9.14 Uniogen: Company Overview
Table 9.15 Uniogen: Buffer Manufacturing Service Portfolio
Table 9.16 Uniogen: Recent Developments and Future Outlook
Table 10.1 Buffer Manufacturing System Providers: List of Partnerships and Collaborations, 2017-2023
Table 13.1 Buffer Manufacturing Systems: Distribution by Type of System
Table 13.2 Buffer Manufacturing Systems: Distribution by Mode of Operation
Table 13.3 Buffer Manufacturing Systems: Distribution by Scale of Operation
Table 13.4 Buffer Manufacturing Systems: Distribution by Vessel Fabrication Material(s)
Table 13.5 Buffer Manufacturing Systems: Distribution by Type of System and Type of Vessel Fabrication Material(s)
Table 13.6 Buffer Manufacturing Systems: Distribution by System Mobility Option
Table 13.7 Buffer Manufacturing Systems: Distribution by Feature(s) of Buffer Manufacturing System
Table 13.8 Buffer Manufacturing Systems: Distribution by Integrated Technique(s)
Table 13.9 Buffer Manufacturing Systems: Distribution by Buffer Manufacturing Process
Table 13.10 Buffer Manufacturing Systems: Distribution by Type of Buffer Form(s)
Table 13.11 Buffer Manufacturing Systems: Distribution by Bioprocessing Method
Table 13.12 Buffer Manufacturing System Providers: Distribution by Year of Establishment
Table 13.13 Buffer Manufacturing System Providers: Distribution by Location of Headquarters
Table 13.14 Buffer Manufacturing System Providers: Distribution by Company Size
Table 13.15 Most Active Players: Distribution by Number of Products Offered
Table 13.16 Buffer Manufacturing Service Providers: Distribution by Year of Establishment
Table 13.17 Buffer Manufacturing Service Providers: Distribution by Company Size
Table 13.18 Buffer Manufacturing Service Providers: Distribution by Location of Headquarters
Table 13.19 Buffer Manufacturing Service Providers: Distribution by Location of Facilities
Table 13.20 Buffer Manufacturing Service Providers: Distribution by Scale of Operation
Table 13.21 Buffer Manufacturing Service Providers: Distribution by Type of Buffer(s) Provided
Table 13.22 Buffer Manufacturing Service Providers: Distribution by Buffer(s) Manufactured
Table 13.23 Buffer Manufacturing Service Providers: Distribution by Buffer Formulation
Table 13.24 Buffer Manufacturing Service Provider: Distribution by Buffer Packaging Format
Table 13.25 Buffer Manufacturing Service Providers: Distribution by Compatible Biologic(s)
Table 13.26 Buffer Manufacturing Service Providers: Distribution by Application Area(s)
Table 13.27 Buffer Manufacturing Service Providers: Distribution by Type of Service
Table 13.28 Most Active Players: Distribution by Number of Facilities
Table 13.29 Most Active Players: Distribution by Number of Services Offered
Table 13.30 Partnerships and Collaborations: Distribution by Year of Partnership
Table 13.31 Partnerships and Collaborations: Distribution by Type of Partnership
Table 13.32 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 13.33 Partnerships and Collaborations: Distribution by Type of Partner
Table 13.34 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Table 13.35 Partnerships and Collaborations: Distribution by Company Size
Table 13.36 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
Table 13.37 Partnerships and Collaborations: Distribution by Local and International Agreements
Table 13.38 Partnerships and Collaborations: Distribution by Intracontinental and Intercontinental Agreements
Table 13.39 Most Active Players: Distribution by Number of Partnerships
Table 13.40 Global Buffer Manufacturing Systems Market, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 13.41 Buffer Manufacturing Systems Market: Distribution by Scale of Operation, 2023 and 2035 (USD Million)
Table 13.42 Buffer Manufacturing Systems Market for Preclinical and Clinical Scale, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 13.43 Buffer Manufacturing Systems Market for Commercial Scale, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 13.44 Buffer Manufacturing Systems Market: Distribution by Key Geographical Regions, 2023 and 2035 (USD Million)
Table 13.45 Buffer Manufacturing Systems Market in North America, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 13.46 Buffer Manufacturing Systems Market in Europe, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 13.47 Buffer Manufacturing Systems Market in Asia Pacific, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)
Table 13.48 Buffer Manufacturing Systems Market in Rest of the World, Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Asahi Kasei
  • A&C (a subsidiary of Actylis)
  • A&C Bio Buffer (a subsidiary of Actylis)
  • AB FIA
  • ABI Scientific
  • Actylis
  • ADS Biotec
  • Agilitech 
  • Ajinomoto
  • AmericanBio
  • ANGUS Chemical Company
  • Antibodies.com
  • AquaPhoenix Scientific
  • ARTeSYN BioSolutions
  • Asahi Kasei
  • Atlas Copco
  • Automated Engineering Services (AES)
  • Avantor
  • Axil Scientific
  • Bio-G (acquired by Emerson)
  • Bio-Link Biological Applied Technologies (Bio-Link)
  • BioLogos
  • Bionova Scientific
  • BioPharm Engineered Systems
  • BioPharma Connections
  • BioPhorum
  • BioSciences Corp
  • Boston BioProducts
  • Broadley-James
  • CANDOR Bioscience
  • Canvax
  • Catalent
  • Celgene
  • Celltheon 
  • Cepham Life Sciences 
  • Ciro Manufacturing Corporation
  • Columbus Chemical Industries (CCI)
  • Contract Laboratory
  • CPAchem
  • Critical Process Systems 
  • Cryogenic Industries (acquired by Nikkiso)
  • Cytiva
  • D.D ENTERPRISES (DDE)
  • Danaher
  • Dashihe Technology 
  • Empirical Bioscience 
  • Erbi Biosystems 
  • Exyte
  • United States Food and Drug Administration (USFDA)
  • Finar
  • ForBioKorea
  • FUJIFILM Irvine Scientific 
  • G&G Technologies
  • GE Healthcare
  • GeminiBio
  • Genentech
  • G-Biosciences (a division of Geno Technology)
  • Hopax Fine Chemicals
  • i-DNA Biotechnology
  • Industrial Service Solutions
  • Inorganic Ventures 
  • Integra Continuous Manufacturing Systems (Integra CMS)
  • Integrated Process Engineers & Constructors (IPEC)
  • Intermountain Life Sciences
  • International Pharmaceutical Quality (IPQ)
  • IsleChem (a subsidiary of Actylis)
  • Kedrion Biopharma
  • Lewa 
  • Liquidyne
  • Lonza
  • MasterFlex (a subsidiary of Avantor)
  • Meissner
  • Merck
  • National Institute for Bioprocessing Research and Training
  • National Society of Black Engineers
  • National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
  • Nilsan Nishotech
  • Optimal Biotech
  • Otto Chemie
  • Pall Corporation
  • Pall-Austar Lifesciences (a subsidiary of Pall Corporation)
  • Parker Hannifin
  • PDC Aseptic Filling Systems (a subsidiary of Meissner)
  • Polaris Pharmaceuticals
  • Prater Industries
  • Prepared Biologicals
  • PROAnalytics
  • Pure Process 
  • Quality Biological
  • ReAgent
  • REPASSA
  • RimBio (a subsidiary of Avantor)
  • Ritter (a subsidiary of Avantor)
  • Sartorius
  • Seoul National University
  • Sepragen
  • Siemens
  • Solumetrics
  • TCS Biosciences
  • Teknova
  • Thermo Fisher Scientific
  • Tofflon
  • Uniogen
  • VWR (a subsidiary of Avantor)
  • Waldeck
  • YaoPharma
  • YMC

Methodology

 

 

Loading
LOADING...